CYFRA 21-1 as a prognostic and predictive marker in advanced non-small cell lung cancer in a prospective trial: CALGB 150304

Por Edelman, Martin J., Hodgson, Lydia, Rosenblatt, Paula Y., Christenson, Robert H., Vokes, Everett, Wang, Xiaofei, Kratzke, Robert
Publicado no J Thorac Oncol (2012)

Optimization of Response Classification Criteria for Patients with Malignant Pleural Mesothelioma

Por Labby, Zacariah E., Armato, Samuel G., Kindler, Hedy L., Dignam, James J., Hasani, Arman, Nowak, Anna K.
Publicado em 2012

Features of Potentially Predictive Biomarkers of Chemotherapeutic Efficacy in Small Cell Lung Cancer

Por Chiappori, Alberto A., Zheng, Zhong, Chen, Tingan, Rawal, Bhupendra, Schell, Michael J., Mullaney, Brian P., Bepler, Gerold
Publicado em 2010

Lung Volume Measurements as a Surrogate Marker for Patient Response in Malignant Pleural Mesothelioma

Por Labby, Zacariah E., Armato, Samuel G., Dignam, James J., Straus, Christopher, Kindler, Hedy L., Nowak, Anna K.
Publicado em 2013

Multi-Modality Mediastinal Staging for Lung Cancer Among Medicare Beneficiaries

Por Farjah, Farhood, Flum, David R., Ramsey, Scott D., Heagerty, Patrick J., Symons, Rebecca Gaston, Wood, Douglas E.
Publicado em 2009

Inhibition of JAK2 Signaling by TG101209 Enhances Radiotherapy in Lung Cancer Models

Por Sun, Yunguang, Moretti, Luigi, Giacalone, Nicholas J, Schleicher, Stephen, Speirs, Christina K., Carbone, David P., Lu, Bo
Publicado em 2011

A systematic analysis of efficacy of second line chemotherapy in sensitive and refractory small cell lung cancer

Por Owonikoko, Taofeek K., Behera, Madhusmita, Chen, Zhengjia, Bhimani, Chandar, Curran, Walter J., Khuri, Fadlo R., Ramalingam, Suresh S.
Publicado em 2012

Frequency of EGFR and KRAS Mutations in Lung Adenocarcinomas in African-Americans

Por Reinersman, J. Matthew, Johnson, Melissa L., Riely, Gregory J., Chitale, Dhananjay A., Nicastri, Anthony D., Soff, Gerald A., Schwartz, Ann G., Sima, Camelia S., Ayalew, Getinet, Lau, Christopher, Zakowski, Maureen F., Rusch, Valerie W., Ladanyi, Marc, Kris, Mark G.
Publicado em 2011

Feasibility of Image-Guided Transthoracic Core Needle Biopsy in the BATTLE Lung Trial

Por Tam, Alda L., Kim, Edward S., Lee, J. Jack, Ensor, Joe E., Hicks, Marshall E., Tang, Ximing, Blumenschein, George R., Alden, Christine M., Erasmus, Jeremy J., Tsao, Anne, Lippman, Scott M., Hong, Waun K., Wistuba, Ignacio I., Gupta, Sanjay
Publicado em 2013

Transitional Cell Carcinoma of the Bladder Manifestating as Malignant Lymphoma with Generalized Lymphadenopathy

Por Kancharla, Venkat Pavan, Gulmi, Frederick A., Agheli, Aref, Degen, Michael, Gohari, Arash, Jiang, Ming, Wang, J.C.
Publicado em 2010

Timing of thoracic irradiation in limited stage small-cell lung cancer: is it still a star on the rise?

Por Manapov, Farkhad, Niyazi, Maximilian, Li, Minglun
Publicado em 2013

Mixed adeno(neuro)endocrine carcinoma arising from the ectopic gastric mucosa of the upper thoracic esophagus

Por Kitajima, Toshihiro, Kaida, Sachiko, Lee, Seigi, Haruta, Shusuke, Shinohara, Hisashi, Ueno, Masaki, Suyama, Koichi, Oota, Yasunori, Fujii, Takeshi, Udagawa, Harushi
Publicado em 2013

Surgical anatomy of the internal thoracic lymph nodes in fresh human cadavers: basis for sentinel node biopsy

Por Barros, Alfredo Carlos S. D., Mori, Lincon Jo, Nishimura, Dolores, Jacomo, Alfredo L.
Publicado no World J Surg Oncol (2016)

QUANTITATIVE CT ANALYSIS, AIRFLOW OBSTRUCTION AND LUNG CANCER IN THE PITTSBURGH LUNG SCREENING STUDY

Por Wilson, David O, Leader, Joseph K, Fuhrman, Carl R, Reilly, John J, Sciurba, Frank C., Weissfeld, Joel L
Publicado em 2011

A phase 1/2 trial of ruxolitinib and erlotinib in patients with EGFR-mutant lung adenocarcinomas with acquired resistance to erlotinib

Por Yu, Helena A., Perez, Leslie, Chang, Qing, Gao, Sizhi P., Kris, Mark G., Riely, Gregory J., Bromberg, Jacqueline
Publicado no J Thorac Oncol (2016)

Physician Preferences for Management of Patients with Stage IIIA NSCLC: Impact of Bulk of Nodal Disease on Therapy Selection

Por Tanner, Nichole T., Gomez, Mario, Rainwater, Chelsea, Nietert, Paul J., Simon, George R., Green, Mark R., Silvestri, Gerard A.
Publicado em 2012

BV6, an IAP antagonist, activates apoptosis and enhances radiosensitization of non-small cell lung carcinoma in vitro

Por Li, Wenyan, Li, Bo, Giacalone, Nicholas J., Torossian, Artour, Sun, Yunguang, Niu, Kathy, Lin-Tsai, Opal, Lu, Bo
Publicado em 2011

Postoperative Radiation Therapy is Associated with Longer Overall Survival in Completely Resected Stage II and III Thymoma – An Analysis of the International Thymic Malignancies In...

Por Rimner, Andreas, Yao, Xiaopan, Huang, James, Antonicelli, Alberto, Ahmad, Usman, Korst, Robert J., Detterbeck, Frank, Gomez, Daniel R.
Publicado no J Thorac Oncol (2016)

Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility

Por Eaton, Keith D., Romine, Perrin E., Goodman, Gary E., Thornquist, Mark D., Barnett, Matt J., Petersdorf, Effie W.
Publicado no J Thorac Oncol (2018)

Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: A phase II Southwest Oncology Group Study (S0415)

Por Gold, Philip J., Goldman, Bryan, Iqbal, Syma, Leichman, Lawrence P., Zhang, Wu, Lenz, Heinz-Josef, Blanke, Charles D.
Publicado em 2010